Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.